Literature DB >> 3912962

Diagnosis of bacterial overgrowth of the small intestine. Comparison of the 14C-D-xylose breath test and jejunal cultures in 60 patients.

J J Rumessen, E Gudmand-Høyer, E Bachmann, T Justesen.   

Abstract

Sixty consecutive patients suspected of having bacterial overgrowth of the small intestine (BOG) had aerobic and anaerobic bacterial cultures made of fasting upper jejunal fluid and also a 14C-D-xylose breath test (XBT). Culture-proven BOG was present in 23 patients. In another 15 patients the presence of BOG was ruled out (diagnoses: irritable bowel syndrome, 8; chronic diarrhoea, 6; and lactose malabsorption, 1). These patients were used as controls. The other 22 of the 60 patients could not be placed in either group owing to the presence of factors known to predispose for BOG; none of them had abnormal jejunal cultures, but several had strong clinical suspicion of BOG. An abnormal XBT, defined as values exceeding upper 90% confidence limits (upper range) of the 15 patient control values within a 4-h period, was observed with the following frequencies in the 23 patients with BOG: after 60 min, 35%; after 120 min, 44%; after 180 min, 61%; and after 240 min, 65%. An abnormal XBT was observed in 41% of the 22 patients with normal jejunal cultures but with predisposition for, and clinical suspicion of, BOG. It is concluded that, compared with a relevant control material, the XBT tends to be rather insensitive and that a negative outcome of jejunal cultures is inadequate to exclude the presence of BOG.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3912962     DOI: 10.3109/00365528509089288

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

1.  Small intestinal bacterial overgrowth, intestinal permeability, and non-alcoholic steatohepatitis.

Authors:  S M Riordan; V M Duncombe; M C Thomas; A Nagree; T D Bolin; C J McIver; R Williams
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 2.  A systematic review of diagnostic tests for small intestinal bacterial overgrowth.

Authors:  Reza Khoshini; Sun-Chuan Dai; Sheila Lezcano; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 3.  Malabsorption testing: a review.

Authors:  P M Ginsburg; P Janefalkar; D T Rubin; E D Ehrenpreis
Journal:  Curr Gastroenterol Rep       Date:  2000-10

4.  Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.

Authors:  Iris Posserud; Per-Ove Stotzer; Einar S Björnsson; Hasse Abrahamsson; Magnus Simrén
Journal:  Gut       Date:  2006-12-05       Impact factor: 23.059

5.  Small intestinal bacterial overgrowth: a comprehensive review.

Authors:  Andrew C Dukowicz; Brian E Lacy; Gary M Levine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-02

6.  Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology.

Authors:  A Danielsson; H Nyhlin; H Persson; U Stendahl; R Stenling; O Suhr
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

7.  Increased accuracy of the carbon-14 D-xylose breath test in detecting small-intestinal bacterial overgrowth by correction with the gastric emptying rate.

Authors:  C S Chang; G H Chen; C H Kao; S J Wang; S N Peng; C K Huang; S K Poon
Journal:  Eur J Nucl Med       Date:  1995-10

Review 8.  Use and abuse of hydrogen breath tests.

Authors:  M Simrén; P-O Stotzer
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

9.  Intestinal microbiota in functional bowel disorders: a Rome foundation report.

Authors:  Magnus Simrén; Giovanni Barbara; Harry J Flint; Brennan M R Spiegel; Robin C Spiller; Stephen Vanner; Elena F Verdu; Peter J Whorwell; Erwin G Zoetendal
Journal:  Gut       Date:  2012-06-22       Impact factor: 23.059

10.  Risk Factors Associated With Upper Aerodigestive Tract or Coliform Bacterial Overgrowth of the Small Intestine in Symptomatic Patients.

Authors:  Matthew Bohm; Andrea Shin; Sean Teagarden; Huiping Xu; Anita Gupta; Robert Siwiec; David Nelson; John M Wo
Journal:  J Clin Gastroenterol       Date:  2020-02       Impact factor: 3.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.